Novel Agents and Combinations in Hodgkin Lymphoma
0 Bekeken
• 07/09/23
0
0
insluiten
administrator
abonnees
Panelists discuss novel agents, such as HDAC inhibitors, being explored in clinical trials for patients with Hodgkin lymphoma.
For more from this discussion, visit http://www.onclive.com/peer-exchange/lymphoma
Laat meer zien
Facebook Reacties
SORT BY-
Top Reacties
-
Laatste Reacties